Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | DHFR | P00374 | 1/20 | 0.31 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.30 |
| ▸ | TUBB | P07437 | 1/20 | 0.30 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.30 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.30 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.30 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.30 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.30 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.30 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.30 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.30 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.30 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.30 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.30 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.30 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18798704 | 0.94 | ALDH1A1 (0.37) | ALDH1A1ACHETUBB1 | |
| SCHEMBL897369 | 0.80 | ACHE (0.39) | ALDH1A1ACHETDP1DHFRTUBB1 | |
| SCHEMBL1304637 | 0.78 | ALDH1A1 (0.37) | ALDH1A1ACHETDP1DHFRCYP3A4 | |
| SCHEMBL13453651 | 0.78 | ALDH1A1 (0.37) | ALDH1A1ACHETDP1DHFRCYP3A4 | |
| SCHEMBL1305179 | 0.78 | ALDH1A1 (0.41) | ALDH1A1ACHETDP1DHFR | |
| SCHEMBL2228168 | 0.76 | ACHE (0.52) | ALDH1A1ACHETUBB4ATUBBTUBA3C | |
| SCHEMBL11904273 | 0.76 | ALDH1A1 (0.36) | ALDH1A1ACHETDP1DHFRCYP3A4 | |
| SCHEMBL21061156 | 0.76 | ALDH1A1 (0.36) | ALDH1A1ACHETDP1DHFRTUBB4A | |
| Hydrochloric Acid SCHEMBL4534575 | 0.76 | ALDH1A1 (0.36) | ALDH1A1ACHETDP1DHFRCYP3A4 | |
| SCHEMBL8398815 | 0.76 | ALDH1A1 (0.44) | ALDH1A1ACHETDP1DHFRTUBB4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1598053-B1 | Use of a composition containing at least one phosphine as majority reducing agent to remove the artificial colour of keratinic fibres | OREAL (FR) | 2006-12-20 | — | — | EP | claimed |
| EP-1598053-A1 | Use of a composition containing at least one phosphine as majority reducing agent to remove the artificial colour of keratinic fibres | L'OREAL (FR) | 2005-11-23 | — | — | EP | claimed |
| US-20050251928-A1 | Method for stripping artificial color from keratin fibers | L'OREAL (FR) | 2005-11-17 | — | — | US | claimed |
| US-20250368598-A1 | CATALYTIC CARBOXYCARBONYLATION OF ALKENES TO FORM ANHYDRIDES | BHATTACHARYA SHRABANTI (US) | 2025-12-04 | — | — | US | disclosed |
| CN-119998255-A | Catalytic carboxycarbonylation of olefins to form anhydrides | 北卡罗来纳大学教堂山分校 | 2025-05-13 | — | — | CN | disclosed |
| EP-4543841-A2 | CATALYTIC CARBOXYCARBONYLATION OF ALKENES TO FORM ANHYDRIDES | The University of North Carolina at Chapel Hill (US) | 2025-04-30 | — | — | EP | disclosed |
| WO-2023250180-A2 | CATALYTIC CARBOXYCARBONYLATION OF ALKENES TO FORM ANHYDRIDES | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2023-12-28 | — | — | WO | disclosed |
| US-20230165771-A1 | PROCESS FOR TREATING KERATIN FIBERS USING PARTICULAR AMINO ACIDS IN HIGH CONCENTRATION | L'OREAL (FR) | 2023-06-01 | — | — | US | disclosed |
| EP-4171490-A1 | PROCESS FOR TREATING KERATIN FIBERS USING PARTICULAR AMINO ACIDS IN HIGH CONCENTRATION | L'OREAL (FR) | 2023-05-03 | — | — | EP | disclosed |
| CN-115996701-A | Method for treating keratin fibres using a high concentration of a specific amino acid | 莱雅公司 | 2023-04-21 | — | — | CN | disclosed |
| WO-2022003040-A1 | PROCESS FOR TREATING KERATIN FIBERS USING PARTICULAR AMINO ACIDS IN HIGH CONCENTRATION | L'OREAL (FR) | 2022-01-06 | — | — | WO | disclosed |
| EP-0987271-A1 | An optically active diaminophosphine ligand-transition metal complex | Ajinomoto Co., Inc. (JP) | 2000-03-22 | — | — | EP | disclosed |
| EP-0984972-A1 | CHIRAL PHOSPHORUS-BASED LIGANDS | Chirotech Technology Limited (GB) | 2000-03-15 | — | — | EP | disclosed |
| US-5892044-A | ASYMMETRICALLY HYDROGENATING 1-(P-METHOXYBENZYL)-3,4,5,6,7,8-HEXAHYDROISOQUINOLINE OR SALT THEREOF IN PRESENCE OF CATALYTICALLY EFFECTIVE OPTICALLY ACTIVE IRIDIUM-PHOSPHINE COMPLEX | LONZA LTD. (CH) | 1999-04-06 | — | — | US | disclosed |
| WO-1998054193-A1 | CHIRAL PHOSPHORUS-BASED LIGANDS | CHIROTECH TECHNOLOGY LIMITED (GB) | 1998-12-03 | — | — | WO | disclosed |
| EP-0739333-B1 | SELECTIVE ASYMMETRIC HYDROGENATION OF DEHYDROAMINO ACID DERIVATIVES USING RHODIUM AND IRIDIUM DIPHOSPHINITE CARBOHYDRATE CATALYST COMPOSITIONS | DU PONT (US) | 1998-10-14 | — | — | EP | disclosed |
| EP-0839135-A1 | PROCESS FOR PREPARING OPTICALLY ACTIVE 1-(P-METHOXYBENZYL)-1,2,3,4,5,6,7,8-OCTAHYDROISOQUINOLINE | LONZA AG (CH) | 1998-05-06 | — | — | EP | disclosed |
| WO-1997003052-A1 | PROCESS FOR PREPARING OPTICALLY ACTIVE 1-(P-METHOXYBENZYL)-1,2,3,4,5,6,7,8-OCTAHYDROISOQUINOLINE | LONZA AG (CH) | 1997-01-30 | — | — | WO | disclosed |
| US-5510507-A | COORDINATION CATALYSTS; EFFICIENT ENANTIOSELECTIVITY | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-04-23 | — | — | US | disclosed |
| US-5481006-A | PREPARATION OF INTERMEDIATES FOR PHARMACEUTICALS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-01-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250368598-A1 | CATALYTIC CARBOXYCARBONYLATION OF ALKENES TO FORM ANHYDRIDES | CA4, CA12, CA14 | ALDH1A1 688/4885ACHE 2398/4885TDP1 3585/4885 |
| US-20230165771-A1 | PROCESS FOR TREATING KERATIN FIBERS USING PARTICULAR AMINO ACIDS IN HIGH CONCENTRATION | KRT18, CKAP4, VIM | ALDH1A1 4235/4885ACHE 3912/4885TDP1 3775/4885 |
| US-20050251928-A1 | Method for stripping artificial color from keratin fibers | KRT18, DSG1, JUP | ALDH1A1 4512/4885ACHE 704/4885TDP1 3996/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.